WGS: GeneDx Corp Projected Sales Volume

Brandmark of GeneDx (WGS)

The projected sales volume in the GURU.Markets chart data shows that the indicator settled at 0.46. GeneDx Holdings Corp. (WGS) dominates sequencing by leveraging AI and a unique exome archive for precise diagnostics. However, aggressive dumping by network laboratories creates pricing pressure, although operating exclusively within the US reliably protects the business from external geopolitical shocks.

WGS - GeneDx Holdings Corp. Company Future Sales over the range 04/28/2023 - 11/18/2026

WGS (GeneDx Corp): analytical breakdowns and indicator data

- stock value and consensus price forecast:
Basic company analysis:GeneDx WGS
Brand item of Sema4

The integration of GeneDx Holdings Corp. (WGS) into pediatric infrastructure and the increasing volume of genetic testing create a sustainable B2B pipeline that directly reflects the dynamics of future inflows. The current sales forecast level measures expected revenue against historical trends and competitors, allowing investors to promptly identify a slowdown in expansion or confirm the asset's status as a high-growth business.

Direct competitors

Company Future Sales Volume TEM (Tempus AI)|Company Future Sales Qiagen Group|Company Projected Revenue Ionis Pharma IONS|RGEN - Company Future Sales Volume|RNA - Company Projected Revenue|Company Future Revenue CRSP (CRISPR Therapeutics AG)|Ultragenyx Pharmaceutical (RARE) - Company Projected Revenue|Company Expected Sales Volume Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Projected Sales Volume|Company Expected Sales Volume Twist Bioscience Corp TWST|Projected Sales Volume TXG|Projected Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Future Sales Volume|BioLife Solutions Inc (BLFS) - Company Expected Sales Volume|wavelifesciences.com - Projected Sales Volume|Maze Therapeutics Corp (MAZE) - Company Future Sales Volume|SION: Projected Sales Volume|Company Revenue Forecast PRME|Company Projected Revenue Taysha Gene Therapies|Company Revenue Forecast QURE (uniQure)|Company Projected Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Revenue Forecast|Company Projected Revenue Solid Biosciences SLDB|OCGN - Company Future Sales Volume|pacb.com - Projected Sales Volume|Benitec (BNTC) - Company Future Sales Volume|DSGN: Projected Sales Volume|RCKT - Company Future Sales|FDMT: Company Future Sales|Company Revenue Forecast LXEO (lexeotx.com)|Company Projected Revenue Korro Bio Inc. (KRRO)|Company Projected Revenue Volume EDIT|Projected Sales Volume SLN (Silence Therapeutics PLC)|Company Future Revenue PRQR|CDXS - Company Projected Revenue|SGMO (Sangamo Therapeutics) - Company Revenue Forecast|NAUT: Projected Sales Volume|Company Revenue Forecast MGX|DTIL (precisionbiosciences.com) - Projected Sales Volume|Company Revenue Forecast GBIO (Generation Bio Co.)|Company Projected Revenue Boundless Bio (BOLD)|Exicure - Company Revenue Forecast|Projected Sales Volume IMNN (imunon.com)|Company Future Sales Phio Pharmaceuticals (PHIO)|MBIO: Company Future Sales Volume|Company Future Revenue RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Company Projected Revenue|APDN - Company Future Sales|Company Future Sales Volume BLUE|Projected Sales Volume immunoprecise.com|Projected Sales Volume OMGA|Company Future Sales Singular Genomics Corp|Regulus Therapeutics - Company Future Sales Volume|SYRS (Syros Pharmaceuticals) - Company Expected Revenue|Telesis Bio Inc. - Projected Sales Volume|Company Future Revenue TCON (TRACON Pharmaceuticals Inc.)|UBX: Projected Sales Volume